Table 1 (abstract P109). The designs of LEVO-CTS and LICORN studies
From: 39th International Symposium on Intensive Care and Emergency Medicine
| Â | LEVO-CTS, N=849 | LICORN, N=335 |
|---|---|---|
Isolated CABG surgery | 66.3% (563/849) | 73.4% (246/335) |
Combined CABG & valve(s) OR valve(s) only surgery | 33.7% (286/849) | 26.6% (89/335) |
Preoperative LVEF limit for enrollment | ≤35% | ≤40% |
Dose of levosimendan | 0.2 micg/kg/min for 1 h, followed by 0.1 for 23 h | 0.1 mic/kg/min for 24 h |
Longest follow-up | 90 days | 180 days |